
Fractional sodium excretion (FENa) was measured in 25 neonates during and after treatment with tobramycin. Mean birthweight of infants was 1.83 kg and mean gestational age was 34.3 weeks. Tobramycin therapy was initiated within 48 hours of birth and levels were maintained within the therapeutic range. Mean FENa values were persistently elevated during treatment and decreased to the normal range within 2 days of stopping antibiotics. Blood urea and creatinine concentrations were normal throughout the period of study. Exposure to the aminoglycoside appears to delay the previously described postnatal decline in FENa, most likely reflecting subtle renal tubular dysfunction.
Respiratory Distress Syndrome, Newborn/drug therapy/*urine, Respiratory Distress Syndrome, Newborn, Sodium, Infant, Newborn, Creatinine/blood, Aminoglycosides/therapeutic use, Tobramycin/*therapeutic use, Aminoglycosides, Sodium/*urine, Creatinine, Tobramycin, Humans, Urea, Urea/blood
Respiratory Distress Syndrome, Newborn/drug therapy/*urine, Respiratory Distress Syndrome, Newborn, Sodium, Infant, Newborn, Creatinine/blood, Aminoglycosides/therapeutic use, Tobramycin/*therapeutic use, Aminoglycosides, Sodium/*urine, Creatinine, Tobramycin, Humans, Urea, Urea/blood
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
